热景生物
(688068)
| 流通市值：28.48亿 | | | 总市值：28.48亿 |
| 流通股本：9247.47万 | | | 总股本：9247.47万 |
| 报告期 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 116,124,860.44 | 541,251,205.97 | 406,916,772.66 | 307,007,061.27 |
| 营业收入 | 116,124,860.44 | 541,251,205.97 | 406,916,772.66 | 307,007,061.27 |
| 二、营业总成本 | 123,890,515.38 | 589,237,493.62 | 401,559,759.11 | 263,337,262.01 |
| 营业成本 | 47,567,259.59 | 232,994,996.71 | 146,092,036.85 | 103,979,488 |
| 税金及附加 | 877,301.32 | 4,688,384.81 | 3,393,554.27 | 2,355,534.67 |
| 销售费用 | 38,573,495.92 | 171,153,585.54 | 130,802,159.01 | 77,340,824.44 |
| 管理费用 | 22,005,975.53 | 91,734,458.55 | 53,121,058.88 | 33,526,587.27 |
| 研发费用 | 22,667,361.22 | 131,447,368.91 | 99,168,834.05 | 68,117,516.96 |
| 财务费用 | -7,800,878.2 | -42,781,300.9 | -31,017,883.95 | -21,982,689.33 |
| 其中:利息费用 | - | 1,008,798.69 | - | - |
| 其中:利息收入 | 7,974,995.44 | 39,587,026.49 | 13,195,584.77 | 19,366,191.74 |
| 加:公允价值变动收益 | 14,864,529.05 | -5,154,677.61 | -16,563,336.07 | -6,231,071.01 |
| 加:投资收益 | -5,182,455.32 | -17,159,387.06 | -11,010,386.26 | 405,746.09 |
| 资产处置收益 | 1,752,079.42 | -642,723.74 | -65,476.25 | -65,476.25 |
| 资产减值损失(新) | - | -11,613,584.87 | 5,471,151.24 | 35,904.16 |
| 信用减值损失(新) | - | 12,096,896.34 | 12,385,138.12 | 739,547.61 |
| 其他收益 | 1,776,703.3 | 87,670,096.15 | 50,201,494.2 | 47,025,963.59 |
| 营业利润平衡项目 | 0 | 0 | 0 | 0 |
| 四、营业利润 | 5,445,201.51 | 17,210,331.56 | 45,775,598.53 | 85,580,413.45 |
| 加:营业外收入 | 78,676.47 | 2,597,470.65 | 2,034,630.88 | 1,898,645.2 |
| 减:营业外支出 | 420,715 | 6,302,828.57 | 2,660,871.76 | 1,391,341.72 |
| 利润总额平衡项目 | 0 | 0 | 0 | 0 |
| 五、利润总额 | 5,103,162.98 | 13,504,973.64 | 45,149,357.65 | 86,087,716.93 |
| 减:所得税费用 | 1,572,353.86 | -1,548,890.57 | -1,786,127.2 | 9,691,700.24 |
| 六、净利润 | 3,530,809.12 | 15,053,864.21 | 46,935,484.85 | 76,396,016.69 |
| 持续经营净利润 | 3,530,809.12 | - | - | 76,396,016.69 |
| 归属于母公司股东的净利润 | 5,054,819.8 | 27,382,940.5 | 54,381,071.28 | 84,768,666.87 |
| 少数股东损益 | -1,524,010.68 | -12,329,076.29 | -7,445,586.43 | -8,372,650.18 |
| (一)基本每股收益 | 0.06 | 0.31 | 0.61 | 0.95 |
| (二)稀释每股收益 | 0.06 | 0.31 | 0.61 | 0.95 |
| 八、其他综合收益 | - | -86,482.81 | -97,183.48 | -348,880.58 |
| 归属于母公司股东的其他综合收益 | - | -83,190.33 | -103,287.77 | -352,610.12 |
| 九、综合收益总额 | 3,530,809.12 | 14,967,381.4 | 46,838,301.37 | 76,047,136.11 |
| 归属于母公司股东的综合收益总额 | 5,054,819.8 | 27,299,750.17 | 54,277,783.51 | 84,416,056.75 |
| 归属于少数股东的综合收益总额 | -1,524,010.68 | -12,332,368.77 | -7,439,482.14 | -8,368,920.64 |
| 公告日期 | 2024-04-30 | 2024-04-30 | 2023-10-31 | 2023-08-30 |
| 审计意见(境内) | | 标准无保留意见 | | |